Current mitraclip experience, safety and feasibility in the Netherlands

Purpose Data on MitraClip procedural safety and efficacy in the Netherlands are scarce. We aim to provide an overview of the Dutch MitraClip experience. Methods We pooled anonymised demographic and procedural data of 1151 consecutive MitraClip patients, from 13 Dutch hospitals. Data was collected by product specialists in collaboration with local operators. Effect on mitral regurgitation was intra-procedurally assessed by transoesophageal echocardiography. Technical success and device success were defined according to modified definitions of the Mitral Valve Academic Research Consortium (MVARC... Mehr ...

Verfasser: Rahhab, Z. (Zouhair)
Kortlandt, F.A.
Velu, J.F.
Schurer, R.A.J. (Remco)
Delgado, V. (Victoria)
Tonino, P. (Pim)
Boven, A.J.
Van den Branden, B.J.L.
Kraaijeveld, A.O.
Voskuil, M. (Michiel)
Hoorntje, J.C.A. (Jan)
Van Wely, M.
Houwelingen, K.G. (K.) van
Bleeker, G.B. (Gabe)
Rensing, B.J.W.M. (Benno)
Kardys, I. (Isabella)
Baan Jr., J. (Jan)
Heyden, J.A. (Jan) van der
Mieghem, N.M. (Nicolas) van
Dokumenttyp: Artikel
Erscheinungsdatum: 2017
Schlagwörter: Mitral valve / Mitral valve therapies / Valvular heart disease
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28785497
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/100404

Purpose Data on MitraClip procedural safety and efficacy in the Netherlands are scarce. We aim to provide an overview of the Dutch MitraClip experience. Methods We pooled anonymised demographic and procedural data of 1151 consecutive MitraClip patients, from 13 Dutch hospitals. Data was collected by product specialists in collaboration with local operators. Effect on mitral regurgitation was intra-procedurally assessed by transoesophageal echocardiography. Technical success and device success were defined according to modified definitions of the Mitral Valve Academic Research Consortium (MVARC). Results Median age was 76 (interquartile range 69-82) years and 59% were males. Patients presented with ≥moderate mitral regurgitation and a predominance of functional mitral regurgitation (72%). Overall, 611 (53%) patients were treated with one Clip, 486 (42%) with ≥2 Clips and 54 (5%) received no Clip. The number of patients with ≥2 Clips increased from 22% in 2009 to 52% in 2016.Device success and technical succe